Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 25, n. 1, 2024. DOI: 10.7175/fe.v25i1.1568. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1568. Acesso em: 29 dec. 2025.